In addition to having anti–angiogenic activity, leading to cancer growth inhibition, azurin also inhibits cancer cell growth through interference with the phosphorylation of receptor tyrosine kinase EphB2 that is often hyper-expressed in cancer cells. Here, EPHB2 is linked to cancer.